Robert P. Perrillo

13.3k total citations · 6 hit papers
119 papers, 10.1k citations indexed

About

Robert P. Perrillo is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Robert P. Perrillo has authored 119 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Epidemiology, 99 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Robert P. Perrillo's work include Hepatitis C virus research (92 papers), Hepatitis B Virus Studies (87 papers) and Liver Disease Diagnosis and Treatment (58 papers). Robert P. Perrillo is often cited by papers focused on Hepatitis C virus research (92 papers), Hepatitis B Virus Studies (87 papers) and Liver Disease Diagnosis and Treatment (58 papers). Robert P. Perrillo collaborates with scholars based in United States, Canada and United Kingdom. Robert P. Perrillo's co-authors include Jules L. Dienstag, Eugene R. Schiff, Karen L. Lindsay, Andrew L. Mason, Robert G. Gish, Janice K. Albrecht, Henry C. Bodenheimer, Ira M. Jacobson, John A. Payne and William D. Carey and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Robert P. Perrillo

115 papers receiving 9.7k citations

Hit Papers

Treatment of Chronic Hepa... 1989 2026 2001 2013 1989 1995 1990 1992 1999 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
    1989 1.4k citations Gary L. Davis, Eugene R. Schiff et al. New England Journal of Medicine profile →
  2. A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection
    1995 680 citations Jules L. Dienstag, Robert P. Perrillo et al. New England Journal of Medicine profile →
  3. A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B
    1990 664 citations Robert P. Perrillo, Henry C. Bodenheimer et al. New England Journal of Medicine profile →
  4. Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
    1992 570 citations Leonard B. Seeff, Elizabeth C. Wright et al. New England Journal of Medicine profile →
  5. Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection
    1999 523 citations Andrew L. Mason, Robert P. Perrillo et al. Hepatology profile →
  6. American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
    2014 373 citations Robert P. Perrillo, Robert G. Gish et al. Gastroenterology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert P. Perrillo 8.9k 8.4k 1.0k 621 469 119 10.1k
Alessandra Mangia 6.1k 0.7× 6.4k 0.8× 759 0.7× 618 1.0× 500 1.1× 202 7.7k
Antonina Smedile 6.7k 0.7× 6.6k 0.8× 592 0.6× 413 0.7× 584 1.2× 199 8.1k
Paul J. Pockros 6.2k 0.7× 6.5k 0.8× 1.1k 1.0× 650 1.0× 580 1.2× 190 8.5k
Savino Bruno 5.7k 0.6× 5.9k 0.7× 625 0.6× 407 0.7× 508 1.1× 133 7.0k
Fumitaka Suzuki 9.1k 1.0× 9.6k 1.1× 1.1k 1.1× 766 1.2× 866 1.8× 404 11.5k
M. Diago 10.8k 1.2× 10.7k 1.3× 990 1.0× 976 1.6× 493 1.1× 131 12.8k
Christophe Hézode 7.3k 0.8× 8.0k 0.9× 1.6k 1.5× 718 1.2× 336 0.7× 175 8.9k
Marc Bourlière 7.0k 0.8× 7.6k 0.9× 1.3k 1.3× 499 0.8× 462 1.0× 305 8.8k
Johnson Y.N. Lau 6.1k 0.7× 6.6k 0.8× 771 0.8× 772 1.2× 277 0.6× 134 8.2k
Kenneth E. Sherman 5.8k 0.7× 6.7k 0.8× 2.2k 2.1× 433 0.7× 375 0.8× 250 8.7k

Countries citing papers authored by Robert P. Perrillo

Since Specialization
Citations

This map shows the geographic impact of Robert P. Perrillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert P. Perrillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert P. Perrillo more than expected).

Fields of papers citing papers by Robert P. Perrillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert P. Perrillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert P. Perrillo. The network helps show where Robert P. Perrillo may publish in the future.

Co-authorship network of co-authors of Robert P. Perrillo

This figure shows the co-authorship network connecting the top 25 collaborators of Robert P. Perrillo. A scholar is included among the top collaborators of Robert P. Perrillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert P. Perrillo. Robert P. Perrillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feld, Jordan J., Abdus S. Wahed, Michael Fried, et al.. (2023). Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial. The American Journal of Gastroenterology. 118(7). 1226–1236. 13 indexed citations
2.
Terrault, Norah A., Anna S. Lok, Abdus S. Wahed, et al.. (2022). Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B. The American Journal of Gastroenterology. 118(7). 1214–1225. 11 indexed citations
3.
Feld, Jordan J., Wendy C. King, Marc G. Ghany, et al.. (2022). Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection. Clinical Gastroenterology and Hepatology. 21(6). 1503–1512.e4. 3 indexed citations
4.
Sung, Joseph J.�Y., Stefan Zeuzem, E. Jenny Heathcote, et al.. (2008). Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B. Journal of Hepatology. 48(5). 728–735. 117 indexed citations
5.
Perrillo, Robert P., Robert G. Gish, Marion G. Peters, et al.. (2006). Chronic Hepatitis B: A Critical Appraisal of Current Approaches to Therapy. Clinical Gastroenterology and Hepatology. 4(2). 233–248. 24 indexed citations
6.
Nair, Satheesh, Anna Mae Diehl, Mark Wiseman, Gist H. Farr, & Robert P. Perrillo. (2004). Metformin in the treatment of non‐alcoholic steatohepatitis: a pilot open label trial. Alimentary Pharmacology & Therapeutics. 20(1). 23–28. 298 indexed citations
7.
Schiff, Eugene R., Jules L. Dienstag, Selim Karayalçın, et al.. (2003). Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders. Journal of Hepatology. 38(6). 818–826. 95 indexed citations
8.
Perrillo, Robert P., Ching‐Lung Lai, Yun‐Fan Liaw, et al.. (2002). Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B. Hepatology. 36(1). 186–194. 238 indexed citations
9.
10.
Seeff, Leonard B., Blaine Hollinger, Harvey J. Alter, et al.. (2001). Long–Term Mortality and Morbidity of Transfusion–Associated Non–A, Non–B, and Type C Hepatitis: A National Heart, Lung, and Blood Institute Collaborative Study. Hepatology. 33(2). 455–463. 243 indexed citations
11.
Perrillo, Robert P.. (1997). The role of liver biopsy in hepatitis C. Hepatology. 26(Supplement 3). 57S–61S. 136 indexed citations
12.
Dienstag, Jules L., et al.. (1995). A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection. New England Journal of Medicine. 333(25). 1657–1661. 680 indexed citations breakdown →
13.
Perrillo, Robert P.. (1994). The management of chronic hepatitis B. The American Journal of Medicine. 96(1). S34–S40. 16 indexed citations
14.
Mason, Andrew L., Mark R. Wick, Heather M. White, et al.. (1993). Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology. 105(1). 237–244. 50 indexed citations
15.
Perrillo, Robert P.. (1993). Interferon for hepatitis B: US experience.. Gut. 34(2 Suppl). S95–S96. 2 indexed citations
16.
Perrillo, Robert P.. (1993). Hepatitis B: transmission and natural history.. Gut. 34(2 Suppl). S48–S49. 17 indexed citations
17.
Perrillo, Robert P.. (1993). Antiviral therapy of chronic hepatitis B: past, present, and future. Journal of Hepatology. 17. S56–S63. 22 indexed citations
18.
Mason, Andrew L., et al.. (1992). Hepatitis B Virus Dna in Peripheral–Blood Mononuclear Cells in Chronic Hepatitis B After Hbsag Clearance. Hepatology. 16(1). 36–41. 88 indexed citations
19.
Roodman, Stanford T., et al.. (1991). HLA class I antigen expression as a measure of response to antiviral therapy of chronic hepatitis B. Hepatology. 13(5). 820–825. 9 indexed citations
20.
Davis, Gary L., Eugene R. Schiff, Karen L. Lindsay, et al.. (1990). Treatment of chronic hepatitis C with recombinant α-interferon. A multicentre randomized, controlled trial. Journal of Hepatology. 11. S31–S35. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Mangia Breakdown of academic impact, for papers by Antonina Smedile Breakdown of academic impact, for papers by Paul J. Pockros Breakdown of academic impact, for papers by Savino Bruno Breakdown of academic impact, for papers by Fumitaka Suzuki Breakdown of academic impact, for papers by M. Diago Breakdown of academic impact, for papers by Christophe Hézode Breakdown of academic impact, for papers by Marc Bourlière Breakdown of academic impact, for papers by Johnson Y.N. Lau Breakdown of academic impact, for papers by Kenneth E. Sherman
Rankless by CCL
2026